April 2014
Volume 55, Issue 13
Free
ARVO Annual Meeting Abstract  |   April 2014
Choroidal Thickness changes in β-Thalassemia Syndromes using Enhanced Depth Imaging Optical Coherence Tomography (EDI-OCT)
Author Affiliations & Notes
  • Eleonora Benatti
    University of Milan, Milan, Italy
    Fondazione IRCCS Ca Granda Ospedale Maggiore Policlinico, Milan, Italy
  • Laura Dell'Arti
    University of Milan, Milan, Italy
    Fondazione IRCCS Ca Granda Ospedale Maggiore Policlinico, Milan, Italy
  • Giulio Barteselli
    University of Milan, Milan, Italy
    Shiley Eye Center UCSD, San Diego, CA
  • Fabio Ferrari
    University of Milan, Milan, Italy
  • Chiara Mapelli
    Fondazione IRCCS Ca Granda Ospedale Maggiore Policlinico, Milan, Italy
  • Francesco Viola
    University of Milan, Milan, Italy
    Fondazione IRCCS Ca Granda Ospedale Maggiore Policlinico, Milan, Italy
  • Roberto Ratiglia
    University of Milan, Milan, Italy
    Fondazione IRCCS Ca Granda Ospedale Maggiore Policlinico, Milan, Italy
  • Footnotes
    Commercial Relationships Eleonora Benatti, None; Laura Dell'Arti, None; Giulio Barteselli, None; Fabio Ferrari, None; Chiara Mapelli, None; Francesco Viola, None; Roberto Ratiglia, None
  • Footnotes
    Support None
Investigative Ophthalmology & Visual Science April 2014, Vol.55, 277. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Eleonora Benatti, Laura Dell'Arti, Giulio Barteselli, Fabio Ferrari, Chiara Mapelli, Francesco Viola, Roberto Ratiglia; Choroidal Thickness changes in β-Thalassemia Syndromes using Enhanced Depth Imaging Optical Coherence Tomography (EDI-OCT). Invest. Ophthalmol. Vis. Sci. 2014;55(13):277.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose: To determine and quantify choroidal thickness changes in patients affected by β-thalassemia syndromes with normal fundus appearance and with pseudoxanthoma elasticum (PXE)-like fundus changes.

Methods: We performed subfoveal EDI-OCT scans in the right eyes of 120 consecutive patients with β-thalassemia syndromes, as well as in a control group of 35 healthy volunteers. Subfoveal choroidal thickness (SCT) and choroidal thickness (CT) at 3000 µm temporally, nasally, superiorly, and inferiorly to the fovea were measured. Multiple comparisons were performed between eyes of healthy volunteers and eyes of thalassemic patients divided into three groups depending on the presence of PXE-like changes: 76 eyes without fundus abnormalities, 20 eyes with peau d'orange and 24 eyes with peau d’orange and angioid streaks.

Results: No significant differences with regard to age, sex, and refractive error were present among groups. Compared to control group (299,74µm), SCT was significantly reduced in thalassemic eyes with normal fundus (256,51µm, p=0.026) and in thalassemic eyes with peau d’orange and angioid streaks (246,79 µm, p=0.040). Thalassemic eyes with only peau d’orange had SCT similar to control group (297,55 µm). Similar pattern of results was obtained superiorly and temporally to the fovea between groups. No significant differences were observed between groups nasally and inferiorly to the fovea.

Conclusions: Thalassemic patients with normal fundus appearance have thinner choroid than control subjects, however the presence of PXE-like changes affects significantly choroidal thickness. Choroidal thickness increases if peau d’orange is present, however it reduces when angioid streaks develop. This change in the choroid supports the hypothesis that peau d’orange and angioid streaks represent different stages of the disease, similar to PXE. Progressive calcification of the Bruch’s membrane that leads to peau d’orange development in β-thalassemia may induce a temporary inflammatory response and therefore a thickening of choroidal tissue. Angioid streaks, signs of excessive and long-term calcification of the Bruch’s membrane, are associated with increased thinning indicating a potential pathogenetic and prognostic role. Non-invasive choroidal thickness measurement might be an useful tool to monitor disease stages and progression.

Keywords: 452 choroid • 552 imaging methods (CT, FA, ICG, MRI, OCT, RTA, SLO, ultrasound) • 550 imaging/image analysis: clinical  
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×